IHC of paraffin-embedded Adenocarcinoma of ovary tissue using anti-PSMC3 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded prostate tissue using anti-PSMC3 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Carcinoma of prostate tissue using anti-PSMC3 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded liver tissue using anti-PSMC3 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Adenocarcinoma of breast tissue using anti-PSMC3 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded pancreas tissue using anti-PSMC3 mouse monoclonal antibody. (Dilution 1:50).
IHC of paraffin-embedded Kidney tissue using anti-PSMC3 mouse monoclonal antibody. (Dilution 1:50).
Anti-PSMC3 mouse monoclonal antibody immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY PSMC3.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PSMC3 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PSMC3.
Flow cytometry of Jurkat cells, using anti-PSMC3 antibody, (Red) compared to a nonspecific negative control antibody (Blue).
Flow cytometry of HeLa cells, using anti-PSMC3 antibody, (Red) compared to a nonspecific negative control antibody (Blue).
HEK293T cells transfected with either pCMV6-ENTRY PSMC3 (Red) or empty vector control plasmid (Blue) were immunostained with anti-PSMC3 mouse monoclonal, and then analyzed by flow cytometry.